Mucinex Sinus Max Sinus Pressure Severe Congestion
NDC 72854-219, Oxymetazoline HCI, spray, from Reckitt Benckiser LLC.
- Product NDC
- 72854-219
- Status
- Listed
- Labeler
- Reckitt Benckiser LLC
- Dosage form
- SPRAY
- Route
- NASAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72854-219 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXYMETAZOLINE HYDROCHLORIDE.05 g/100mL
Pharmacologic classes
Imidazolines [CS]; Increased Sympathetic Activity [PE]; Vasoconstriction [PE]; Vasoconstrictor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72854-219-11 | 72854021911 | 1 BOTTLE, PUMP in 1 CARTON (72854-219-11) / 22 mL in 1 BOTTLE, PUMP |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 72854-219 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72854-219 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72854-219. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.